Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 16 hours ago Drug news

Updated positive results for phase III CHECKMATE 214 study of Opdivo + Yervoy versus sunitinib to treat metastatic renal cell carcinoma. - BMS

-Bristol-Myers Squibb Company announced updated results from the Phase III CheckMate -214 study evaluating the combination of Opdivo (nivolumab) plus...

Added 16 hours ago Drug news

Five year positive follow up of CHECKMATE 025 study of Opdivo versus everolimus for metastatic renal cell carcinoma .- BMS

Bristol-Myers Squibb Company announced five-year follow-up results from the Phase III CheckMate -025 study, which continue to demonstrate that treatment...

Added 16 hours ago Drug news

Positive results from phase III VISIBLE 2 trial of subcutaneous Entyvio to treat moderate to severe Crohn's disease.- Takeda

-Takeda Pharmaceutical Company Limited announced results from the phase III VISIBLE 2 clinical trial evaluating the efficacy and safety of...

Added 16 hours ago Drug news

FDA approves Twirla weekly application contraceptive patch.-Agile Therapeutics

Agile Therapeutics, Inc., a women’s healthcare company, announced that the FDA has approved Twirla (levonorgestrel and ethinyl estradiol) transdermal system....

Industry news

Added 6 days ago Industry news

Zealand Pharma A/S acquires Valeritas Holdings.

Zealand Pharma A/S, announces a bid to acquire substantially all assets from Valeritas Holdings, Inc. for a total cash consideration...

Added 11 days ago Industry news

Merck Inc.to spin-off products from its Women’s Health, trusted Legacy Brands, and Biosimilars businesses into a new, yet-to-be-named, independent, publicly traded company.

Merck announced its intention to spin-off products from its Women’s Health, trusted Legacy Brands, and Biosimilars businesses into a new,...

Added 12 days ago Industry news

Cerecor acquires Avei Genomic Medicine

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and...

 

Advocacy News

Added 2 years ago Advocacy news

CAR-T breakthrough in most common childhood cancer

“A new frontier in cancer treatment” for acute lymphoblastic leukemia (ALL).